Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1617 1636 1645
This examiner grants 50% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18836272 | NOVEL LIVE MULTI-ANTIGENIC RECOMBINANT VACCINE AGAINST TUBERCULOSIS | Non-Final OA | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA |
| 19100617 | COMPOSITIONS, KITS, METHODS, AND METHODS OF ADMINISTRATION RELATING TO EDWARDSIELLA PISCICIDA VACCINE AND/OR ANTIGEN DELIVERY VECTOR SYSTEMS | Non-Final OA | University of Florida Research Foundation, Inc. |
| 18694893 | STRAIN FOR PRODUCING HIGH CONCENTRATION L-GLUTAMIC ACID AND METHOD FOR PRODUCING L-GLUTAMIC ACID USING THE SAME | Non-Final OA | CJ CHEILJEDANG CORPORATION |
| 18570962 | STRAIN FOR PRODUCING HIGHLY CONCENTRATED L-GLUTAMIC ACID, AND L-GLUTAMIC ACID PRODUCTION METHOD USING SAME | Non-Final OA | CJ CHEILJEDANG CORPORATION |
| 19005379 | METHOD OF EFFICIENT CITRAMALATE PRODUCTION FROM BROWN MACROALGAE BIOMASS BY ENGINEERED VIBRIO SP. DHG | Non-Final OA | INHA UNIVERSITY RESEARCH AND BUSINESS FOUNDATION |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy